Compare SAP SE (SAP) vs Twist Bioscience Corp (TWST) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
SAP SE vs Twist Bioscience Corp — how do they compare? SAP SE trades at $207.24 (market cap $240.81B), while Twist Bioscience Corp trades at $124 (market cap $7.72B). The key difference: SAP SE is far larger — about 31.2× Twist Bioscience Corp's market cap, and SAP SE pays a 1.4% dividend while Twist Bioscience Corp pays none. Which is the better fit depends on your goals.
| SAP | TWST | |
|---|---|---|
Market Cap | $240.81B | $7.72B |
Sector | Technology | Health |
52-Week High | $280.46 | $124.88 |
52-Week Low | $146.38 | $24.16 |
Enterprise Value | $239.52B | $7.65B |
Dividend Yield | 1.4% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About SAP SE
Founded in 1972 by former IBM employees, SAP provides database technology and enterprise resource planning software to enterprises around the world. Across more than 180 countries, the company serves 440,000 customers, approximately 80% of which are small to medium-size enterprises.
Read more on SAP →About Twist Bioscience Corp
Twist Bioscience Corp is a synthetic biology company. It develops a disruptive DNA synthesis platform to industrialize the engineering of biology. The company's DNA synthesis platform utilizes a proprietary semiconductor-based synthetic DNA manufacturing process that synthesizes DNA on silicon instead of on traditional well plastic plates to enable the production of high-quality synthetic DNA faster and affordable as well as overcomes inefficiencies. Powering cost-effective, rapid high-throughput synthesis, it enables researchers to rapidly realize opportunities ahead. Geographically, it derives a majority of revenue from the United States.
Read more on TWST →
